Viewing Study NCT04717635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2026-05-23 @ 12:38 PM
Study NCT ID: NCT04717635
Status: COMPLETED
Last Update Posted: 2025-05-06
First Post: 2020-12-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Onset Still's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Canakinumab View
None AOSD View
None IL-1β View
None Japanese participants View